Status:
UNKNOWN
The Nocebo Effect: a Prospective Study of Informed Consent as a Factor in the Prevalence of SSRI's Side Effects
Lead Sponsor:
Shalvata Mental Health Center
Conditions:
Depression
Eligibility:
All Genders
18-66 years
Phase:
NA
Brief Summary
In this study we invetigate the influence of the nocebo effect (as part of obtaining informed consent) on the prevalence of side-effects. The study is prospective, focusing on the connection between w...
Detailed Description
In this study the investigators wish to inquire whether the nature of the explenation given to the patient as part of informed consent has an effect on the prevalence of side-effects. The study will t...
Eligibility Criteria
Inclusion
- age 18-60
- started on an SSRI
Exclusion
- Psychotic spectrum disorder
- Suicidality
- Sensitivity to SSRI
- Has taken the prescribed SSRI in the past
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2013
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01200615
Start Date
October 1 2010
End Date
October 1 2013
Last Update
September 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shalvata Mental Health Center
Hod HaSharon, Israel